Q4 2020 Holdings
Filed 2021-02-16 | 28 holdings | $39.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.9M | 481,094 | 40.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.6M | 1,336,275 | 21.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.5M | 760,025 | 21.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $6.2M | 356,431 | 15.8% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $12.5K | 852,871 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $12.2K | 423,708 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $9.0K | 532,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $8.9K | 298,839 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $8.8K | 1,274,261 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $8.5K | 1,486,107 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $7.7K | 125,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.3K | 330,315 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.2K | 467,368 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.0K | 347,500 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $6.6K | 1,854,278 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $6.1K | 3,150,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.7K | 178,565 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $4.5K | 97,143 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.4K | 133,503 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $4.3K | 467,796 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $4.3K | 1,765,901 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.2K | 158,827 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.9K | 83,782 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.4K | 231,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.8K | 250,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $2.1K | 264,690 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $2.0K | 925,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $1.1K | 100,000 | 0.0% |